Lands of Opportunity: Frost & Sullivan Examines the Mobile Markets in Angola and MozambiqueCAPE TOWN, South Africa - Angola and Mozambique are amongst the most promising telecommunications markets in Africa and have high potential for growth. Both are emerging from decades of civil war into boom periods of reconstruction. Peopleclick and eQuest Renew Multi-Year PartnershipLONDON and RALEIGH, North Carolina - - Partnership Will Provide Global Job Posting Support and Expanded Job Board Management Services to Peopleclick Clients Noront Resources Provides Exploration UpdateTORONTO - - Symbol: NOT:TSX-V - SHARES OUTSTANDING: 154,578,457 - FULLY DILUTED: 161,033,457 Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research PerformanceAMSTERDAM - - Allows Institutions to Optimize Strategic Funding, Hiring and Collaboration Decisions Frost & Sullivan Looks at Investment Opportunities in Russia’s Rail Transport Development ProgramLONDON - The economic recession has caused a dramatic decrease in rail freight traffic volumes in Russia. While Russian rail operators have diversified their freight structure to preserve their market positions, some of the key rail manufacturers have partially halted production. Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of BiopharmaceuticalsUPPSALA, Sweden - - Financing Led by SLS Invest Will Fund Gyros to Profitability Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million) in an equity fundraising led by SLS Invest, the Company’s leading shareholder. The new funds will enable Gyros to drive the further commercialization of its Gyrolab technology. This unique technology platform is rapidly gaining traction with leading pharma and biotech companies as well as CROs and CMOs focused on the efficient, accelerated development of new biopharmaceuticals. A growing list of more than 20 companies worldwide, including Merck, MedImmune, GSK, Amgen, Pfizer, Ablynx and ThromboGenics, currently benefit from Gyros’ unique Gyrolab systems, with an installed base of 40 systems. Aerospace Industry to Aid European Large Scale Metrology Market, Finds Frost & SullivanLONDON - The European large scale micro metrology market is anticipated to register low growth during the first few quarters of 2009 due to the economic downturn. An upturn in the economic situation by the last quarter of 2009 is set to spur market growth with resurgent demand from the automotive industry. With an operational and capital expenditure freeze in all end-user segments, growth in this market is dependent on demand from the aerospace industry. Economic Meltdown Temporarily Restrains Growth in the Middle East Water and Wastewater Treatment Equipment Markets, Finds Frost & SullivanDUBAI, United Arab Emirates - The market for water and wastewater treatment equipment in Gulf Cooperation Council (GCC) countries experienced rapid growth during 2008 driven by huge investments in infrastructure, real estate, petrochemicals, oil and gas and other sectors. However, the sub-prime mortgage crisis that hit western economies changed the business climate and there was a considerable decline in demand for most commodities. Crude oil prices plummeted to about $50 per barrel from a historic high of $145 per barrel, making investors wary of funding new projects. eSearchVision 5.0 Increases Productivity by up to 40 PercentLONDON - eSearchVision is happy to announce the launch of the 5th version of their Search Engine Marketing (SEM) optimisation software. In eSearchVision V5, the intuitive interface considerably simplifies the process of campaign creation, modification and control. Advertisers will have access to an improved suite of features including report analysis and audit procedures - among other features. The result is a 40 percent increase in scalability and productivity. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)S. MAMEDE DO CORONADO, Portugal - Data presented today, in Budapest, demonstrated that add-on treatment with the novel, once-daily anti-epileptic Zebinix(R)* (eslicarbazepine acetate; ESL) resulted in a marked and sustained decrease in seizure frequency over the long-term(1). Secret to Multiplay Success in Latin America Requires Mass Market Appeal, Finds PyramidCAMBRIDGE, Massachusetts - As operators continue to exhaust the high-income consumer segments in Latin America, the bundling strategies with the best chance of success involve broadened offerings that will attract lower-income households to broadband and pay-TV, according to a new report from Pyramid Research (www.pyr.com), the telecom research arm of the Light Reading Communications Network (www.lightreading.com). JetBrains Releases IntelliJ IDEA 9 Milestone 1PRAGUE - - Milestone Release Gives a Glimpse of Things to Come in Intellij Idea 9, Makes Available Major New Features |
